{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:56:39Z","timestamp":1787165799379,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008868","name":"Jiangsu Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["No.BE2019723"],"award-info":[{"award-number":["No.BE2019723"]}],"id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80616-7","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T01:31:11Z","timestamp":1732239071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integrative metabolomics and proteomics reveal the effect and mechanism of Zi Qi decoction on alleviating liver fibrosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Xiaoying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianci","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"3","key":"80616_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T. & Brenner, D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 18 (3), 151\u2013166 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"80616_CR2","doi-asserted-by":"crossref","unstructured":"Roehlen, N., Crouchet, E. & Baumert, T. F. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells ;9(4). (2020).","DOI":"10.3390\/cells9040875"},{"issue":"2","key":"80616_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79 (2), 516\u2013537 (2023).","journal-title":"J. Hepatol."},{"issue":"16","key":"80616_CR4","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1111\/febs.15327","volume":"287","author":"G Soto-Heredero","year":"2020","unstructured":"Soto-Heredero, G., Gomez de Las Heras, M. M., Gabande-Rodriguez, E., Oller, J. & Mittelbrunn, M. Glycolysis - a key player in the inflammatory response. FEBS J. 287 (16), 3350\u20133369 (2020).","journal-title":"FEBS J."},{"issue":"10","key":"80616_CR5","doi-asserted-by":"publisher","first-page":"9783","DOI":"10.1007\/s11033-022-07474-2","volume":"49","author":"C Hu","year":"2022","unstructured":"Hu, C. et al. Immune cell metabolism and metabolic reprogramming. Mol. Biol. Rep. 49 (10), 9783\u20139795 (2022).","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"80616_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/ATVBAHA.113.303041","volume":"34","author":"Y Xu","year":"2014","unstructured":"Xu, Y. et al. Endothelial PFKFB3 plays a critical role in angiogenesis. Arterioscler. Thromb. Vasc Biol. 34 (6), 1231\u20131239 (2014).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"80616_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-physiol-020518-114731","volume":"81","author":"X Li","year":"2019","unstructured":"Li, X., Kumar, A. & Carmeliet, P. Metabolic pathways fueling the endothelial cell drive. Annu. Rev. Physiol. 81, 483\u2013503 (2019).","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"80616_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/j.gastro.2019.03.013","volume":"157","author":"MB Hilscher","year":"2019","unstructured":"Hilscher, M. B. et al. Mechanical Stretch increases expression of cxcl1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension. Gastroenterology 157 (1), 193\u2013209e9 (2019).","journal-title":"Gastroenterology"},{"issue":"3","key":"80616_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jhep.2022.03.029","volume":"77","author":"T Greuter","year":"2022","unstructured":"Greuter, T. et al. Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo. J. Hepatol. 77 (3), 723\u2013734 (2022).","journal-title":"J. Hepatol."},{"key":"80616_CR10","doi-asserted-by":"publisher","first-page":"112442","DOI":"10.1016\/j.jep.2019.112442","volume":"251","author":"H Li","year":"2020","unstructured":"Li, H. Advances in anti hepatic fibrotic therapy with traditional Chinese medicine herbal formula. J. Ethnopharmacol. 251, 112442 (2020).","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"80616_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1478-3231.2007.01527.x","volume":"27","author":"JM Luk","year":"2007","unstructured":"Luk, J. M. et al. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation. Liver Int. 27 (7), 879\u2013890 (2007).","journal-title":"Liver Int."},{"key":"80616_CR12","doi-asserted-by":"publisher","first-page":"108863","DOI":"10.1016\/j.biopha.2019.108863","volume":"114","author":"FF Cai","year":"2019","unstructured":"Cai, F. F. et al. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomed. Pharmacother. 114, 108863 (2019).","journal-title":"Biomed. Pharmacother"},{"issue":"2","key":"80616_CR13","first-page":"46","volume":"11","author":"Z Ming","year":"1995","unstructured":"Ming, Z. Clinical observation on ziqi ruangan mixture for 120 cases with chronic active Hepatitis and Posthcaptitic Cirrhosos. J. Nanjing Univ. Traditional Chin. Med. 11 (2), 46\u201347 (1995).","journal-title":"J. Nanjing Univ. Traditional Chin. Med."},{"key":"80616_CR14","doi-asserted-by":"publisher","first-page":"e929438","DOI":"10.12659\/MSM.929438","volume":"27","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. Zi Qi decoction alleviates liver fibrosis by inhibiting the toll-like receptor 4 (TLR4)-related nuclear factor kappa b (NF-kappaB) and mitogen-activated protein kinase (MAPK) signaling pathways. Med. Sci. Monit. 27, e929438 (2021).","journal-title":"Med. Sci. Monit."},{"key":"80616_CR15","doi-asserted-by":"publisher","first-page":"989995","DOI":"10.3389\/fphar.2022.989995","volume":"13","author":"P Gong","year":"2022","unstructured":"Gong, P. et al. Tandem mass tag-based proteomics analysis reveals the multitarget mechanisms of Phyllanthus emblica against liver fibrosis. Front. Pharmacol. 13, 989995 (2022).","journal-title":"Front. Pharmacol."},{"issue":"3","key":"80616_CR16","doi-asserted-by":"publisher","first-page":"e0173598","DOI":"10.1371\/journal.pone.0173598","volume":"12","author":"YN Song","year":"2017","unstructured":"Song, Y. N. et al. Metabolomic mechanisms of gypenoside against liver fibrosis in rats: an integrative analysis of proteomics and metabolomics data. PLoS One. 12 (3), e0173598 (2017).","journal-title":"PLoS One"},{"issue":"3","key":"80616_CR17","doi-asserted-by":"publisher","first-page":"e12762","DOI":"10.1111\/cpr.12762","volume":"53","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Curcumol attenuates liver sinusoidal endothelial cell angiogenesis via regulating Glis-PROX1-HIF-1alpha in liver fibrosis. Cell. Prolif. 53 (3), e12762 (2020).","journal-title":"Cell. Prolif."},{"key":"80616_CR18","doi-asserted-by":"publisher","first-page":"154759","DOI":"10.1016\/j.phymed.2023.154759","volume":"114","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Blockade of KLF5\/LDH-A feedback loop contributes to Curcumol inhibition of sinusoidal endothelial cell glycolysis and mitigation of liver fibrosis. Phytomedicine 114, 154759 (2023).","journal-title":"Phytomedicine"},{"issue":"5930","key":"80616_CR19","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (5930), 1029\u20131033 (2009).","journal-title":"Science"},{"key":"80616_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2022.11.001","volume":"68","author":"L Ye","year":"2022","unstructured":"Ye, L., Jiang, Y. & Zhang, M. Crosstalk between glucose metabolism, lactate production and immune response modulation. Cytokine Growth Factor. Rev. 68, 81\u201392 (2022).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"11","key":"80616_CR21","doi-asserted-by":"publisher","first-page":"e2003732","DOI":"10.1002\/advs.202003732","volume":"8","author":"M Li","year":"2021","unstructured":"Li, M. et al. DDIT3 directs a dual mechanism to Balance Glycolysis and oxidative phosphorylation during glutamine deprivation. Adv. Sci. (Weinh). 8 (11), e2003732 (2021).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"10","key":"80616_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer. 16 (10), 619\u2013634 (2016).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"80616_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1172\/JCI127515","volume":"130","author":"NS Sharma","year":"2020","unstructured":"Sharma, N. S. et al. Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. J. Clin. Invest. 130 (1), 451\u2013465 (2020).","journal-title":"J. Clin. Invest."},{"issue":"4","key":"80616_CR24","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1007\/s10753-021-01442-x","volume":"44","author":"Y Wang","year":"2021","unstructured":"Wang, Y. & Liu, Y. Neutrophil-Induced Liver Injury and interactions between neutrophils and liver sinusoidal endothelial cells. Inflammation 44 (4), 1246\u20131262 (2021).","journal-title":"Inflammation"},{"issue":"16","key":"80616_CR25","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/ars.2014.6108","volume":"23","author":"B Pulli","year":"2015","unstructured":"Pulli, B. et al. Myeloperoxidase-hepatocyte-stellate cell cross talk promotes hepatocyte injury and fibrosis in experimental nonalcoholic steatohepatitis. Antioxid. Redox Signal. 23 (16), 1255\u20131269 (2015).","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"80616_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera, A., Soehnlein, O. & Kenne, E. Neutrophils in chronic inflammatory diseases. Cell. Mol. Immunol. 19 (2), 177\u2013191 (2022).","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"80616_CR27","first-page":"632","volume":"12","author":"DP Higgins","year":"2005","unstructured":"Higgins, D. P., Hemsley, S. & Canfield, P. J. Association of uterine and salpingeal fibrosis with chlamydial hsp60 and hsp10 antigen-specific antibodies in Chlamydia-infected koalas. Clin. Diagn. Lab. Immunol. 12 (5), 632\u2013639 (2005).","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"Suppl 1","key":"80616_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12072-017-9808-z","volume":"12","author":"G D\u2019Amico","year":"2018","unstructured":"D\u2019Amico, G. et al. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis. Hepatol. Int. 12 (Suppl 1), 34\u201343 (2018).","journal-title":"Hepatol. Int."},{"key":"80616_CR29","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 2, 16018 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"80616_CR30","doi-asserted-by":"publisher","first-page":"28705","DOI":"10.3390\/ijms161226126","volume":"16","author":"M Hong","year":"2015","unstructured":"Hong, M. et al. Current status of Herbal Medicines in Chronic Liver Disease Therapy: the Biological effects, molecular targets and future prospects. Int. J. Mol. Sci. 16 (12), 28705\u201328745 (2015).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"80616_CR31","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan, D. & Kim, Y. O. Evolving therapies for liver fibrosis. J. Clin. Invest. 123 (5), 1887\u20131901 (2013).","journal-title":"J. Clin. Invest."},{"issue":"28","key":"80616_CR32","doi-asserted-by":"publisher","first-page":"e2119038119","DOI":"10.1073\/pnas.2119038119","volume":"119","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. RNA m(1)a methylation regulates glycolysis of cancer cells through modulating ATP5D. Proc. Natl. Acad. Sci. U S A. 119 (28), e2119038119 (2022).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1\u20132","key":"80616_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.bbrc.2015.10.096","volume":"468","author":"K Lim","year":"2015","unstructured":"Lim, K., Yoon, B. H. & Ha, C. H. O-Linked N-acetylglucosaminylation of Sp1 interferes with Sp1 activation of glycolytic genes. Biochem. Biophys. Res. Commun. 468 (1\u20132), 349\u2013353 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"80616_CR34","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.jhep.2021.02.012","volume":"74","author":"H Gilgenkrantz","year":"2021","unstructured":"Gilgenkrantz, H., Mallat, A., Moreau, R. & Lotersztajn, S. Targeting cell-intrinsic metabolism for antifibrotic therapy. J. Hepatol. 74 (6), 1442\u20131454 (2021).","journal-title":"J. Hepatol."},{"issue":"12","key":"80616_CR35","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","volume":"71","author":"J Rao","year":"2022","unstructured":"Rao, J. et al. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut 71 (12), 2539\u20132550 (2022).","journal-title":"Gut"},{"key":"80616_CR36","doi-asserted-by":"crossref","unstructured":"Delgado, M. E., Cardenas, B. I., Farran, N. & Fernandez, M. Metabolic reprogramming of liver fibrosis. Cells ;10(12). (2021).","DOI":"10.3390\/cells10123604"},{"issue":"20","key":"80616_CR37","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.121.053960","volume":"144","author":"LY Lee","year":"2021","unstructured":"Lee, L. Y. et al. Interferon-gamma impairs human coronary artery endothelial glucose metabolism by tryptophan catabolism and activates fatty acid oxidation. Circulation 144 (20), 1612\u20131628 (2021).","journal-title":"Circulation"},{"issue":"1","key":"80616_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41573-019-0040-5","volume":"19","author":"X Zhao","year":"2020","unstructured":"Zhao, X., Kwan, J. Y. Y., Yip, K., Liu, P. P. & Liu, F. F. Targeting metabolic dysregulation for fibrosis therapy. Nat. Rev. Drug Discov. 19 (1), 57\u201375 (2020).","journal-title":"Nat. Rev. Drug Discov"},{"key":"80616_CR39","doi-asserted-by":"crossref","unstructured":"Lu, Q. et al. Detecting migration and infiltration of neutrophils in mice. J. Vis. Exp. 2020(156).","DOI":"10.3791\/60543"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80616-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80616-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80616-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T03:33:00Z","timestamp":1732246380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80616-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80616"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80616-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28943"}}